Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
默克(US:MRK) Businesswire·2025-09-19 18:50RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Receives Positive EU CHMP Opinion for ENFLONSIAâ,,g (clesrovimab) for the Prevention of RSV in Infants During Their First RSV Season. ...